|
APITD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.1766999998335E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.19359999999292E-05 |
| Normal-vs-Stage2 |
3.578300E-04 |
| Normal-vs-Stage3 |
2.616800E-04 |
| Normal-vs-Stage4 |
8.818100E-04 |
| Stage1-vs-Stage2 |
1.546160E-01 |
| Stage1-vs-Stage3 |
1.291590E-01 |
| Stage1-vs-Stage4 |
5.595800E-01 |
| Stage2-vs-Stage3 |
9.534000E-01 |
| Stage2-vs-Stage4 |
6.260000E-01 |
| Stage3-vs-Stage4 |
6.948200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.64949999998032E-06 |
| Normal-vs-AfricanAmerican |
7.63360000000102E-05 |
| Normal-vs-Asian |
6.130100E-02 |
| Caucasian-vs-AfricanAmerican |
6.775000E-01 |
| Caucasian-vs-Asian |
1.995150E-01 |
| AfricanAmerican-vs-Asian |
1.748980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.7432000000438E-06 |
| Normal-vs-Female |
3.61530000003718E-06 |
| Male-vs-Female |
3.090800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.91379999999431E-05 |
| Normal-vs-Extreme_Weight |
6.44289999999215E-05 |
| Normal-vs-Obese |
3.029700E-04 |
| Normal-vs-Extreme_Obese |
2.812200E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.324200E-01 |
| Normal_Weight-vs-Obese |
5.355600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.528400E-01 |
| Extreme_Weight-vs-Obese |
9.632600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.949200E-01 |
| Obese-vs-Extreme_Obese |
8.216400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.779650E-03 |
| Normal-vs-Age(41-60Yrs) |
5.7483999999941E-05 |
| Normal-vs-Age(61-80Yrs) |
1.99729999994513E-06 |
| Normal-vs-Age(81-100Yrs) |
1.551780E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.808010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.086400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.710200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.973200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.044200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.007600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.943600E-03 |
| Normal-VS-Type2 PRCC |
2.39180000027872E-07 |
| Normal-VS-KIRP CIMP |
1.00570000105549E-08 |
| Normal-VS-Unclassified PRCC |
2.87980000002186E-06 |
| Type1 PRCC-VS-Type2 PRCC |
2.221600E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.86614999999613E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
2.637300E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.024100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.787400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.128000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.23549999999184E-05 |
| Normal-vs-N1 |
1.08339999971285E-07 |
| Normal-vs-N2 |
3.173900E-04 |
| N0-vs-N1 |
2.194200E-01 |
| N0-vs-N2 |
3.905800E-01 |
| N1-vs-N2 |
7.080000E-01 |
|
|
